Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation

Xu Tan, Shifeng Lou, Li Gao et al.|Current Medical Science|2023

Cited by 8